Biology Reference
In-Depth Information
Del Casar JM, Carreno G, Gonzalez LO, Junquera S, Gonzalez-Reyes S, Gonzalez JM, Bongera
M, Merino AM and Vizoso FJ (2010) Expression of metalloproteases and their inhibitors in
primary tumors and in local recurrences after mastectomy for breast cancer. J Cancer Res Clin
Oncol 136(7):1049-1058
Deryugina EI, Conn EM, Wortmann A, Partridge JJ, Kupriyanova TA, Ardi VC, Hooper JD,
Quigley JP (2009) Functional role of cell surface CUB domain-containing protein 1 in tumor
cell dissemination. Mol Cancer Res 7(8):1197-1211
Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metas-
tasis Rev 25(1):9-34
Deryugina EI, Quigley JP (2010) Pleiotropic roles ofmatrixmetalloproteinases in tumor angiogenesis:
Contrasting, overlapping and compensatory functions. Biochim Biophys Acta 1803(1):103-120
Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW, Strongin AY (2001)
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation
of MMP-2 in breast carcinoma cells. Exp Cell Res 263(2):209-223
Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY (2002) Processing of integrin
alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast
carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.
J Biol Chem 277(12):9749-9756
Deryugina EI, Zijlstra A, Partridge JJ, Kupriyanova TA, Madsen MA, Papagiannakopoulos T,
Quigley JP (2005) Unexpected effect of matrix metalloproteinase down-regulation on vascular
intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of
dissemination. Cancer Res 65(23):10959-10969
Devy L, Huang L, Naa L, Yanamandra N, Pieters H, Frans N, Chang E, Tao Q, Vanhove M,
Lejeune A, van Gool R, Sexton DJ, Kuang G, Rank D, Hogan S, Pazmany C, Ma YL,
Schoonbroodt S, Nixon AE, Ladner RC, Hoet R, Henderikx P, Tenhoor C, Rabbani SA,
Valentino ML, Wood CR, Dransfield DT (2009) Selective inhibition of matrix metalloprotei-
nase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res 69(4):1517-1526
Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro SA,
Parks WC (2001) Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1)
integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 276
(31):29368-29374
Eck SM, Cote AL, Winkelman WD, Brinckerhoff CE (2009) CXCR4 and matrix metalloprotei-
nase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibro-
blasts exposed to factors secreted by breast cancer cells. Mol Cancer Res 7(7):1033-1044
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression.
Nat Rev Cancer 2(3):161-174
Elenbaas B, Weinberg RA (2001) Heterotypic signaling between epithelial tumor cells and
fibroblasts in carcinoma formation. Exp Cell Res 264(1):169-184
Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev
Cancer 8(8):579-591
Ellsworth RE, Seebach J, Field LA, Heckman C, Kane J, Hooke JA, Love B, Shriver CD (2009)
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis
26(3):205-213
Erez N, Truitt M, Olson P, Hanahan D (2010) Cancer-associated fibroblasts are activated in
incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent
manner. Cancer Cell 17(2):135-147
Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ (2009) Hypoxia-
induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the
premetastatic niche. Cancer Cell 15(1):35-44
Ezhilarasan R, Jadhav U, Mohanam I, Rao JS, Gujrati M, Mohanam S (2009) The hemopexin
domain of MMP-9 inhibits angiogenesis and retards the growth of intracranial glioblastoma
xenograft in nude mice. Int J Cancer 124(2):306-315
